Methods

Mapping translocation breakpoints by next-generation sequencing

    • 1 Max Planck Institute for Molecular Genetics, 14195 Berlin, Germany;
    • 2 International Max-Planck Research School for Computational Biology and Scientific Computing, 14195 Berlin, Germany;
    • 3 Department of Infectious Diseases and Immunology, Faculty of Veterinary Medicine, Utrecht University, 3508 TC Utrecht, The Netherlands;
    • 4 Department of Genetics, Hospital Universitario La Paz, 28046 Madrid, Spain;
    • 5 Practice of Human Genetics, 81379 Munich, Germany;
    • 6 Centre of Human Genetics, 82152 Martinsried, Germany;
    • 7 Department of Medical Genetics, Eberhard Karls University, 72076 Tuebingen, Germany;
    • 8 Institut für Klinische Genetik, Olgahospital, 70176 Stuttgart, Germany
Published March 7, 2008. Vol 18 Issue 7, pp. 1143-1149. https://doi.org/10.1101/gr.076166.108
Download PDF Please log-in to or register for your personal account in order to access PDF Cite Article Permissions Share
cover of Genome Research Vol 36 Issue 4
Current Issue:

Abstract

Balanced chromosome rearrangements (BCRs) can cause genetic diseases by disrupting or inactivating specific genes, and the characterization of breakpoints in disease-associated BCRs has been instrumental in the molecular elucidation of a wide variety of genetic disorders. However, mapping chromosome breakpoints using traditional methods, such as in situ hybridization with fluorescent dye-labeled bacterial artificial chromosome clones (BAC-FISH), is rather laborious and time-consuming. In addition, the resolution of BAC-FISH is often insufficient to unequivocally identify the disrupted gene. To overcome these limitations, we have performed shotgun sequencing of flow-sorted derivative chromosomes using “next-generation” (Illumina/Solexa) multiplex sequencing-by-synthesis technology. As shown here for three different disease-associated BCRs, the coverage attained by this platform is sufficient to bridge the breakpoints by PCR amplification, and this procedure allows the determination of their exact nucleotide positions within a few weeks. Its implementation will greatly facilitate large-scale breakpoint mapping and gene finding in patients with disease-associated balanced translocations.

Loading
Loading
Back to top